Literature DB >> 9032368

Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant.

P N Nyambi1, P Lewi, M Peeters, W Janssens, L Heyndrickx, K Fransen, K Andries, M Vanden Haesevelde, J Heeney, P Piot, G van der Groen.   

Abstract

Here we report on the use of spectral map analysis of time-paired sequential neutralization data of 11 serum samples of a chimpanzee naturally infected with a simian immunodeficiency virus (SIVcpz-ant) and 8 primary consecutive SIVcpz-ant isolates, taken at about 4-month intervals. The analysis reveals the existence of three SIVcpz-ant isolate and serum neutralization clusters. Each cluster groups virus isolates and/or sera based on similarities of their neutralization spectra. On average, neutralization escape mutants emerged after 15 months and mounted a neutralization response approximately 8 months later. The entire gp160 regions of eight consecutive isolates were sequenced and analyzed by a new statistical method called polygram, which allowed the deduction of amino acid sequence motifs of gp160 which were specific for SIVcpz-ant isolates belonging to the same isolate neutralization clusters. Changes in specific amino acid quadruplets in V1, V2, C3, V4, V5, and CD4 domains of gp120 and gp40 were seen to correlate with the neutralization clusters with most of the specific changes occurring in the V4 region. This method of analysis may facilitate an understanding of the study of the dynamic interplay between human immunodeficiency virus (HIV) and host neutralization responses as well as providing possible insights into mechanisms of persistence of HIV-1-related lentiviruses in their natural hosts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032368      PMCID: PMC191341     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Spectral mapping, a technique for classifying biological activity profiles of chemical compounds.

Authors:  P J Lewi
Journal:  Arzneimittelforschung       Date:  1976

2.  Confirmation of hepatitis C virus positive blood donors by immunoblotting and polymerase chain reaction.

Authors:  H De Beenhouwer; H Verhaert; H Claeys; C Vermylen
Journal:  Vox Sang       Date:  1992       Impact factor: 2.144

3.  Rapid generation of sequence variation during primary HIV-1 infection.

Authors:  S Pang; Y Shlesinger; E S Daar; T Moudgil; D D Ho; I S Chen
Journal:  AIDS       Date:  1992-05       Impact factor: 4.177

4.  Coexistence and competition in HIV infections.

Authors:  M A Nowak; R M May
Journal:  J Theor Biol       Date:  1992-12-07       Impact factor: 2.691

5.  Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient.

Authors:  E C Holmes; L Q Zhang; P Simmonds; C A Ludlam; A J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

6.  V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patients.

Authors:  N L Michael; K E Davis; L D Loomis-Price; T C VanCott; D S Burke; R R Redfield; D L Birx
Journal:  AIDS       Date:  1996-02       Impact factor: 4.177

7.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection.

Authors:  L Q Zhang; P MacKenzie; A Cleland; E C Holmes; A J Brown; P Simmonds
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape.

Authors:  M Arendrup; A Sönnerborg; B Svennerholm; L Akerblom; C Nielsen; H Clausen; S Olofsson; J O Nielsen; J E Hansen
Journal:  J Gen Virol       Date:  1993-05       Impact factor: 3.891

9.  Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.

Authors:  J P Moore; D D Ho
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence.

Authors:  L Pedroza Martins; N Chenciner; S Wain-Hobson
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

View more
  7 in total

1.  Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12.

Authors:  M B Zwick; L L Bonnycastle; A Menendez; M B Irving; C F Barbas; P W Parren; D R Burton; J K Scott
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes.

Authors:  P N Nyambi; A Nádas; H A Mbah; S Burda; C Williams; M K Gorny; S Zolla-Pazner
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Multiple restrictions of human immunodeficiency virus type 1 in feline cells.

Authors:  Carsten Münk; Jörg Zielonka; Hannelore Constabel; Björn-Philipp Kloke; Benjamin Rengstl; Marion Battenberg; Francesca Bonci; Mauro Pistello; Martin Löchelt; Klaus Cichutek
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

4.  Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals.

Authors:  Phillipe Nyambi; Sherri Burda; Mateusz Urbanski; Leo Heyndrickx; Wouter Janssens; Guido Vanham; Arthur Nadas
Journal:  AIDS Res Hum Retroviruses       Date:  2008-12       Impact factor: 2.205

Review 5.  Simian immunodeficiency virus infection of chimpanzees.

Authors:  Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2005-04       Impact factor: 6.549

6.  Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms.

Authors:  Lucie Etienne; Eric Nerrienet; Matthew LeBreton; Godwin Tafon Bibila; Yacouba Foupouapouognigni; Dominique Rousset; Ahmadou Nana; Cyrille F Djoko; Ubald Tamoufe; Avelin F Aghokeng; Eitel Mpoudi-Ngole; Eric Delaporte; Martine Peeters; Nathan D Wolfe; Ahidjo Ayouba
Journal:  Retrovirology       Date:  2011-01-13       Impact factor: 4.602

7.  Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.

Authors:  Tessa Dieltjens; Leo Heyndrickx; Betty Willems; Elin Gray; Lies Van Nieuwenhove; Katrijn Grupping; Guido Vanham; Wouter Janssens
Journal:  Retrovirology       Date:  2009-12-14       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.